文献速递银屑病与炎症性皮肤病皮肤肿瘤

丹麦全国队列研究:银屑病患者罕见癌症风险

Risk of uncommon cancers in patients with psoriasis: a Danish nationwide cohort study.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2017-10-24

经年龄、性别、社会经济地位和医疗保健使用调整后,接受系统治疗的银屑病患者骨与软骨癌症风险显著升高(HR 4.97 [2.32-10.62],P < 0.0001)。结论进一步提示银屑病患者骨与软骨癌症风险增加。

要点

  • 银屑病患者骨与软骨癌症风险显著升高(HR 4.97)。
  • 该风险见于接受系统治疗的银屑病患者。
  • 罕见癌症定义为丹麦每年每10万人新发病例<100例。

核心结论

  • 接受系统治疗的银屑病患者发生骨与软骨癌症的风险显著升高。

研究设计与样本

  • 丹麦全国队列研究,纳入2008年1月1日至2012年12月31日期间首次因罕见癌症住院诊断的丹麦患者,罕见癌症定义为丹麦每年每10万人新发病例<100例。

主要发现

  • 经年龄、性别、社会经济地位和医疗保健使用调整后,接受系统治疗的银屑病患者骨与软骨癌症的风险比显著升高(HR 4.97 [2.32-10.62],P < 0.0001)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cancer-associated mortality is increased in psoriasis. However, little is known about the risk of less common cancers. OBJECTIVE: We aimed to evaluate the risk of less common cancers in patients with psoriasis compared to persons without psoriasis using a nationwide cohort study. METHODS: Between 1 January 2008 and 31 December 2012, we identified all Danish patients with a first-time hospital diagnosis of a less common cancer defined as <100 new cases/year/100.000 persons in Denmark. The primary endpoint was the occurrence of a diagnosis of cancer. RESULTS: We included 4 361 869 individuals. Of these, 58 138 were classified as having psoriasis. After adjusting for age, sex, socio-economic status and healthcare consumption, we found significantly elevated hazard ratios for cancers of bone and cartilage (HR 4.97 [2.32-10.62], P < 0.0001) in patients with psoriasis on systemic treatment. CONCLUSION: We provide further evidence of an increased cancer of bone and cartilage risk in patients with psoriasis.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Jensen P, Egeberg A, Gislason G, et al. Risk of uncommon cancers in patients with psoriasis: a Danish nationwide cohort study. J Eur Acad Dermatol Venereol. 2017. PMID: 28960478. doi:10.1111/jdv.14610

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。